| Product NDC: | 68788-9849 |
| Proprietary Name: | GAVILAX |
| Non Proprietary Name: | polyethylene glycol-3350 |
| Active Ingredient(s): | 17 g/17g & nbsp; polyethylene glycol-3350 |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68788-9849 |
| Labeler Name: | Preferred Pharmaceuticals, Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA091077 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120329 |
| Package NDC: | 68788-9849-2 |
| Package Description: | 238 g in 1 BOTTLE (68788-9849-2) |
| NDC Code | 68788-9849-2 |
| Proprietary Name | GAVILAX |
| Package Description | 238 g in 1 BOTTLE (68788-9849-2) |
| Product NDC | 68788-9849 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | polyethylene glycol-3350 |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20120329 |
| Marketing Category Name | ANDA |
| Labeler Name | Preferred Pharmaceuticals, Inc |
| Substance Name | POLYETHYLENE GLYCOL 3350 |
| Strength Number | 17 |
| Strength Unit | g/17g |
| Pharmaceutical Classes |